Effects of the Action Observation Therapy and Robotic Rehabilitation on the Upper-Limb Motor Function in Stroke
Can Action Observation Therapy be an Alternative to Robotic Rehabilitation to Improve Upper Extremity Functions in Stroke Patients? A Protocol of Randomized Controlled Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This protocol will investigate the effects of action observation therapy and robotic rehabilitation on upper extremity motor functions in subacute stroke patients. Firstly, for this purpose, conventional rehabilitation approaches will take 60 minutes before both treatment methods in stroke patients. The upper-limb conventional rehabilitation program will be applied to all patients according to their individual needs (60x3x8 minutes/day/week). This program will consist of purposeful clinical exercises with a physiotherapist. After the conventional rehabilitation, one of the groups will receive action observation therapy, while the other will receive robotic rehabilitation. Both additional treatment methods will also be applied for 60 minutes. Treatment durations of both additional treatments are the same (60x3x8 minutes/day/week). Assessments will be made three times (Beginning, 4th week, 8th week).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2022
CompletedFirst Posted
Study publicly available on registry
October 21, 2022
CompletedStudy Start
First participant enrolled
December 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2023
CompletedApril 19, 2024
April 1, 2024
1 year
October 17, 2022
April 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Fugl Meyer Assessment for Upper Extremity
This form is used to detect healing in the upper extremity.
Baseline
Fugl Meyer Assessment for Upper Extremity
This form is used to detect healing in the upper extremity.
End of the 4th week
Fugl Meyer Assessment for Upper Extremity
This form is used to detect healing in the upper extremity.
End of the 8th week
Wolf Motor Function Test
This test is used for the level of motor function.
Baseline
Wolf Motor Function Test
This test is used for the level of motor function.
End of the 4th week
Wolf Motor Function Test
This test is used for the level of motor function.
End of the 8th week
Secondary Outcomes (10)
Demographic Data Form
Baseline
Functional Independence questionnaire
Baseline
Functional Independence questionnaire
End of the 4th week
Functional Independence questionnaire
End of the 8th week
The Stroke-Specific Quality of Life Scale (SS-QoL)
Baseline
- +5 more secondary outcomes
Study Arms (2)
Action Observation Therapy (AOT)
EXPERIMENTALAOT is a method based on the principle that the patient watches the movements of a healthy individual and then tries to imitate them. AOT consists of a monitoring-imitation cycle. A cycle consists of 3 minutes of observation, and 3 minutes of imitation. The intervention will consist of 10 cycles for simple functions. Complex movements will be applied by separating them into their components. The cycle time for each component is the same. Take for example, the cup-reaching function: The first component is the cup-reaching activity. The second component is the glass grip. One cycle will be completed on the first component (6 minutes), then one cycle will be completed for the second component (6 minutes) and one cycle (6 minutes) will be completed for the entire movement. Cycles will follow each other for 60 minutes. For the AOT, 31 different videos were prepared for the shoulder, elbow, and wrist. Applications will be made in the hospital under the supervision of a physiotherapist.
Robotic Rehabilitation
EXPERIMENTALThe robotic rehabilitation application will be performed with the ExoRehab X (HoustonBionics, Inc.) device. There is no engine to create any repulsive-pulling force in this device. It is a system that works entirely with the patient's active movement. Active movements of the shoulder, elbow, and wrist in all directions can be performed with the device. Motion is detected with the help of the device's censor, and the avatar moves on the screen. There are 10 different purposeful games embedded in the device. The device also allows resistance exercise thanks to resistance modules. Which joint will be trained will be determined according to the potential of the patient. For example, if programming will be done for the shoulder, elbow and wrist, the treatment time will be 20 minutes for each joint. Applications will be made in the hospital under the supervision of a physiotherapist.
Interventions
Conventional treatment for the upper extremity will be applied according to the patient's individual needs. A physiotherapist will apply this method in the clinic for 60 minutes. The duration of treatment is 60x3x8 minutes/day/week. Other methods will be applied in addition to the conventional treatment program.
Action Observation Therapy (AOT)
Eligibility Criteria
You may qualify if:
- Between 18-80 aged
- Stroke history in last six months
- Mini-Mental Status Evaluation \>24 points,
- Having an Ability to sit independently,
- Presence of at least half of the range of motion of all joints for the upper extremity,
- Spasticity ≤ 2 according to the Modified Ashworth Scale,
- The Fugl-Meyer Assessment for Upper Extremity score between 20-60,
- Individuals without visual impairment,
- Individuals with normal communication and cooperation skills.
You may not qualify if:
- Having another neurological disease,
- Having any orthopedic problems that may affect the upper extremity,
- Taking neuropsychiatric treatment,
- Individuals who had a botox history or tendon surgery,
- Using neuroleptic drugs,
- Having an ataxia,
- Individuals who attended less than 80% of the total number of sessions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emre Şenocaklead
Study Sites (1)
Marmara University
Istanbul, 34083, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Emre Şenocak, MSc
Marmara University
- STUDY CHAIR
Aysel Yildiz Ozer, PhD
Marmara University
- STUDY DIRECTOR
Elif Korkut, PhD
Bağcılar Education and Research Hospital
- STUDY DIRECTOR
Adem Aktürk, PhD
İstanbul Gelişim University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
October 17, 2022
First Posted
October 21, 2022
Study Start
December 12, 2022
Primary Completion
December 12, 2023
Study Completion
December 12, 2023
Last Updated
April 19, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share